International Journal of Molecular Sciences · 2023 · 12 citations · 14 references
Life SciencesOncologyPharmacologyApoptosisChemotherapySignal TransductionApoptosis In CancerApoptosis PharmacologyApoptosis RegulationBreast Cancer PharmacotherapyCancer Cell SignalingApoptosis Signaling RegulationApoptosis TargetingBreast Cancer ChemotherapyBreast Cancer ProgressionCancer Cell Proliferation InhibitionCell Viability AssaysChemotherapy-induced ApoptosisStat3 Signaling
(VaM) on breast cancer cells, and explored the underlying mechanisms. VaM significantly inhibited cell viability and proliferation and induced apoptosis in a dose-dependent manner. VaM also regulated cell cycle progression and effectively inhibited activation of the STAT3 signaling pathway through SHP-1. Combining VaM with low-dose doxorubicin produced a synergistic effect, highlighting its potential as a promising therapeutic. In vivo, VaM administration inhibited tumor growth and modulated key molecular markers associated with breast cancer progression. Overall, our findings provide strong evidence for the therapeutic potential of VaM in breast cancer treatment and support further studies exploring clinical applications.
14
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2022 · 18.2K citations · Full text
Genetic heterogeneity and cancer drug resistance
Nicholas C. Turner, Jorge S. Reis‐Filho · The Lancet Oncology · 2012 · 452 citations
Past, Present, and Future Challenges in Breast Cancer Treatment
George W. Sledge, Eleftherios P. Mamounas, Gabriel N. Hortobágyi et al. · Journal of Clinical Oncology · 2014 · 275 citations · Full text
Medicine, Cancer Biology, Oncology +17